Anti-androgen

0 marketed 1 in Phase 2 1 in Phase 1

This page covers all Anti-androgen drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Androgen receptor.

Targets

Androgen receptor

Phase 2 pipeline (1)

ADT for 2 years · Tata Memorial Centre · Oncology
Androgen deprivation therapy (ADT) involves the use of medications to suppress the production of androgens, such as testosterone, which can fuel the growth of certain types of cancer.

Phase 1 pipeline (1)

2-Hydroxyflutamide · Lidds AB · Oncology
Anti-androgen receptor antagonist